Walleye Capital’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Walleye Capital's KRYS Position: Q3 2026 in Review
Walleye Capital increased its Krystal Biotech (KRYS) stake by 2,308% in Q3 2026, buying an estimated $95.9K and bringing the position to 289 shares worth $96.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5213.
Walleye Capital first reported a position in KRYS in Q3 2024 and has held it in 4 quarters since. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Walleye Capital held 289 shares of Krystal Biotech worth $96.1K as of Q3 2026.
- Walleye Capital bought 277 Krystal Biotech shares in Q3 2026, an estimated $95.9K.
- Krystal Biotech made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5213 holding.
- Walleye Capital first reported a position in Krystal Biotech in Q3 2024 and has held it in 4 quarters since.
- 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.